The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Aug. 15, 2023
Filed:
Feb. 11, 2021
Applicants:
Memorial Sloan Kettering Cancer Center, New York, NY (US);
Eureka Therapeutics, Inc., Emeryville, CA (US);
Inventors:
Renier J. Brentjens, New York, NY (US);
Eric L. Smith, New York, NY (US);
Cheng Liu, Emeryville, CA (US);
Assignees:
MEMORIAL SLOAN KETTERING CANCER CENTER, New York, NY (US);
EUREKA THERAPEUTICS, INC., Emeryville, CA (US);
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 39/395 (2006.01); C07K 16/28 (2006.01); C07K 14/705 (2006.01); A61K 47/68 (2017.01); A61P 35/00 (2006.01); G01N 33/68 (2006.01);
U.S. Cl.
CPC ...
C07K 16/2878 (2013.01); A61K 47/6849 (2017.08); A61P 35/00 (2018.01); C07K 14/70575 (2013.01); C07K 16/2896 (2013.01); G01N 33/6863 (2013.01); C07K 2317/21 (2013.01); C07K 2317/24 (2013.01); C07K 2317/34 (2013.01); C07K 2317/622 (2013.01); C07K 2317/92 (2013.01); C07K 2319/21 (2013.01); C07K 2319/30 (2013.01); C07K 2319/42 (2013.01); G01N 2333/70578 (2013.01);
Abstract
The presently disclosed subject matter provides antibodies that bind to B-cell maturation antigen (BCMA) and methods of using the same.